Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmicals 投資Agenus 爲腫瘤候選藥物的開發提供資金
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊